Sigachi Industries Limited Stock Price Today (NSE: SIGACHI)
Fundamental Score
Sigachi Industries Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sigachi Industries Limited share price today is ₹31.16, down 1.11% on NSE/BSE as of 16 September 2026. Sigachi Industries Limited (SIGACHI) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹1.19K (Cr). The 52-week high for SIGACHI share price is ₹46.00 and the 52-week low is ₹16.65. At a P/E ratio of 46.51x, SIGACHI is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of -14.57% and a debt-to-equity ratio of 0.26.
Sigachi Industries Limited Share Price Chart — NSE/BSE Historical Performance
Sigachi Industries Limited share price chart: 36.56% return over the past month. 52-week high ₹46.00, 52-week low ₹16.65.
Sigachi Industries Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹32.00 | ₹32.26 | ₹29.81 | ₹31.16 | 52.99L (Cr) | |
| ₹37.80 | ₹37.80 | ₹30.35 | ₹31.51 | 204.92L (Cr) | |
| ₹38.00 | ₹38.50 | ₹36.70 | ₹37.93 | 45.02L (Cr) | |
| ₹35.60 | ₹38.77 | ₹35.36 | ₹37.56 | 135.29L (Cr) | |
| ₹34.54 | ₹35.80 | ₹34.26 | ₹35.27 | 33.97L (Cr) | |
| ₹34.25 | ₹35.82 | ₹33.62 | ₹34.70 | 61.70L (Cr) | |
| ₹35.05 | ₹35.31 | ₹33.88 | ₹34.41 | 24.78L (Cr) | |
| ₹32.55 | ₹35.60 | ₹32.31 | ₹34.74 | 92.15L (Cr) | |
| ₹32.69 | ₹33.55 | ₹32.30 | ₹32.55 | 20.67L (Cr) | |
| ₹31.73 | ₹32.85 | ₹31.40 | ₹32.53 | 17.28L (Cr) |
Sigachi Industries Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹32.69 | ₹38.77 | ₹29.81 | ₹31.16 | -4.68% | |
| ₹24.63 | ₹34.80 | ₹24.63 | ₹32.62 | +32.44% | |
| ₹23.36 | ₹26.94 | ₹21.75 | ₹25.92 | +10.96% | |
| ₹22.30 | ₹25.94 | ₹20.33 | ₹23.83 | +6.86% | |
| ₹20.30 | ₹22.65 | ₹18.99 | ₹21.30 | +4.93% | |
| ₹18.10 | ₹23.80 | ₹17.43 | ₹20.20 | +11.60% | |
| ₹19.61 | ₹20.13 | ₹16.65 | ₹16.92 | -13.72% | |
| ₹20.13 | ₹26.65 | ₹18.92 | ₹20.19 | +0.30% | |
| ₹31.15 | ₹31.90 | ₹19.30 | ₹19.88 | -36.18% | |
| ₹39.18 | ₹40.80 | ₹30.50 | ₹31.12 | -20.57% | |
| ₹36.71 | ₹39.90 | ₹33.55 | ₹38.19 | +4.03% | |
| ₹39.08 | ₹40.85 | ₹36.53 | ₹36.71 | -6.06% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sigachi Industries Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sigachi Industries Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SIGACHI across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (19.43%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (19.91% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.26)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 2.13)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Risk Factors
11 factors identified
Below-Average Return on Equity (-14.57%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-11.98%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 46.51x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-106.74%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-5.44%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-26.39% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (1.46% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (-5.31x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-215.74 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.31%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
High Share Pledging Risk (27.71%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
Sigachi Industries Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Sigachi Industries Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sigachi Industries LimitedSigachi Industr...Selected✓ SIGACHI • 543389 | 3.5/100 | ₹31.16₹31 | ₹1190.68₹1190.68 | 46.51Average 46.5 Average | -14.57%Poor -14.57% Poor | -11.98%Poor -11.98% Poor | 0.26Excellent 0.3 Excellent | 1.46%Average 1.46% Average | 19.91%Excellent 19.91% Excellent | 0.42% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1876.50₹1877 | ₹450228.65₹450228.65 | 37.23Average 37.2 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9425.50₹9426 | ₹249775.75₹249775.75 | 85.52Average 85.5 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4939.50₹4940 | ₹167182.32₹167182.32 | 78.91Average 78.9 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1138.70₹1139 | ₹113642.26₹113642.26 | 25.38Average 25.4 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1370.00₹1370 | ₹110675.45₹110675.45 | 32.82Average 32.8 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1925.50₹1926 | ₹104025.14₹104025.14 | 95.04Average 95.0 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1675.20₹1675 | ₹96391.01₹96391.01 | 26.17Average 26.2 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2099.90₹2100 | ₹96017.92₹96017.92 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1141.40₹1141 | ₹95306.90₹95306.90 | 29.50Average 29.5 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2289.10₹2289 | ₹94539.83₹94539.83 | 46.25Average 46.3 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price450228.65 Cr
- Divi's Laboratories Limited share price249775.75 Cr
- Torrent Pharmaceuticals Limited share price167182.32 Cr
- Zydus Lifesciences Limited share price113642.26 Cr
- Cipla Limited share price110675.45 Cr
Sigachi Industries Limited PE Ratio History
Historical price-to-earnings ratio for SIGACHI — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹2.06 | ₹31.12 | 15.1x |
| FY 2024 | ₹1.54 | ₹49.94 | 32.4x |
| FY 2023 | ₹1.42 | ₹51.40 | 36.2x |
| FY 2022 | ₹1.54 | ₹27.12 | 17.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sigachi Industries Limited Dividend History
Annual cash dividends paid by SIGACHI — dividend yield 0.42%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.28 Cr |
| FY 2024 | ₹3.07 Cr |
| FY 2023 | ₹3.07 Cr |
| FY 2022 | ₹2.30 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Sigachi Industries Limited Quarterly Performance
Latest quarterly metrics for SIGACHI — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-5.44%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-106.74%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
19.91%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
1.46%
Compounded annual net profit growth over 5 years
Sigachi Industries Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SIGACHI — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Sigachi Industries Limited Financial Statements
Annual income statement, balance sheet and cash flow for Sigachi Industries Limited (SIGACHI) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Sigachi Industries Limited
About SIGACHI (Sigachi Industries Limited)
Sigachi Industries Ltd is a prominent Indian manufacturer specializing in microcrystalline cellulose (MCC), a vital excipient used extensively across diverse industries. Their core... business revolves around the production and distribution of high-quality MCC and cellulose powder, catering primarily to the pharmaceutical sector where these materials serve as crucial binders, fillers, and disintegrants in tablet and capsule formulations. Sigachi's product portfolio extends beyond MCC, encompassing a range of cellulose-based derivatives and specialty chemicals designed to meet the evolving needs of their clientele. The company's commitment to innovation and quality has solidified its position as a reliable supplier within the Indian pharmaceutical landscape, driving advancements in drug delivery and formulation technologies. Sigachi's strategic approach involves providing a comprehensive suite of products and services that directly benefit its customers. The company's HiCel, AceCel, CoatCel, GloCel, and BARETab branded MCC products are carefully tailored to meet specific application requirements, offering varying particle sizes and functionalities. Beyond pharmaceuticals, Sigachi also serves the food and nutrition, cosmetic, and chemical industries with specialized ingredients, enabling them to create innovative and effective products. The company further differentiates itself by offering operations and maintenance services in the realm of specialty chemicals, demonstrating its broad expertise and commitment to supporting its clients' overall operational efficiency. Sigachi Industries’ success stems from its customer-centric approach and its emphasis on delivering value-added solutions. The company consistently invests in research and development to enhance its product portfolio and improve manufacturing processes. Sigachi’s dedication to quality control and regulatory compliance assures its customers of the purity and safety of its products. By serving various industry sectors, Sigachi promotes a synergistic approach that fosters collaboration and innovation. The company's growth trajectory is strongly linked to its ability to adapt to the changing needs of its customers and its unwavering focus on excellence.
Company Details
Key Leadership
SIGACHI Share Price: Frequently Asked Questions
What is the current share price of Sigachi Industries Limited?
Sigachi Industries Limited (SIGACHI) trades at ₹31.16 on NSE and BSE. Market cap ₹1.19K (Cr). Educational data only.
What is the P/E ratio of Sigachi Industries Limited?
Sigachi Industries Limited has a P/E of 46.51x vs industry average 34.89x.
What is the Bull Run score for Sigachi Industries Limited?
Sigachi Industries Limited has a Bull Run score of 3.5/100 based on 25+ financial parameters.
Does Sigachi Industries Limited pay dividends?
Sigachi Industries Limited has a dividend yield of 0.42%. Past dividends don't guarantee future payments.
What is the ROE of Sigachi Industries Limited?
Sigachi Industries Limited has ROE of -14.57%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sigachi Industries Limited?
Sigachi Industries Limited has debt-to-equity of 0.26.
Is Sigachi Industries Limited a good investment?
Bull Run gives Sigachi Industries Limited a score of 3.5/100. This is not investment advice — consult a SEBI-registered advisor.